HighTower Advisors
LLY icon

HighTower Advisors’s Eli Lilly LLY Stock Holding History

HighTower Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$8.71K – 3960
2025
Q2 		$8.71K Buy
+200
New +$155K ﹤0.01% 3654
2025
Q1 		– Sell
-100
Closed -$14.2K – 3913
2024
Q4 		$14.2K Sell
100
-100
-50% -$82.8K ﹤0.01% 3566
2024
Q3 		$32.7K Sell
200
-200
-50% -$180K ﹤0.01% 3463
2024
Q2 		$83.2K Sell
400
-9,900
-96% -$7.92M ﹤0.01% 3237
2024
Q1 		$52.9K Buy
+10,300
New +$7.33M ﹤0.01% 3249
2022
Q2 		– Sell
-3
Closed -$7K – 3414
2022
Q1 		$7K Buy
+3
New +$772 ﹤0.01% 3238
2020
Q2 		– Sell
-1,000
Closed -$7K – 2490
2020
Q1 		$7K Buy
+1,000
New +$137K ﹤0.01% 2136
2014
Q2 		– Sell
-500
Closed -$2K – 1666
2014
Q1 		$2K Buy
+500
New +$27.9K ﹤0.01% 1560

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighTower Advisors's LLY Position: Q2 2026 in Review

HighTower Advisors reduced its Eli Lilly (LLY) stake by 0.96% in Q2 2026, selling an estimated $4.33M and leaving 436,561 shares worth $524M. The position accounts for 0.5% of the portfolio, ranked #30.

HighTower Advisors first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $524M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HighTower Advisors held 436,561 shares of Eli Lilly worth $524M as of Q2 2026.
  • HighTower Advisors sold 4,236 Eli Lilly shares in Q2 2026, an estimated $4.33M.
  • Eli Lilly made up 0.5% of HighTower Advisors's portfolio in Q2 2026, its #30 holding.
  • HighTower Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Eli Lilly position peaked at $524M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.